![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
Wild, C. (2004): [Rituximab (MabThera®) as treatment for non-Hodgkin's lymphoma]. HTA-Newsletter 32: p. 3.
Preview |
PDF
- Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
121kB |
Official URL: http://hw.oeaw.ac.at/ita/hta-newsletter?frames=yes
| Item Type: | HTA Newsletter Item |
|---|---|
| Keywords: | Non-Hodgkin's lymphoma (NHL), rituximab (MabThera®), monoclonal antibody, drug therapy, combination therapy |
| Subjects: | WH Hemic and lymphatic systems QW Microbiology. Immunology |
| Related URLs: | |
| References: | 1. NHSC/GB 2004: Rituximab for 1st line lowgrade non-Hodgkin's lymphoma: URL: http://pcpoh.bham.ac.uk/publichealth/horizon/PDF_files/2004reports/Rituximab.pdf. 2. NCCHTA/GB 2004: Rituximab for aggressive non-Hodgkin's lymphoma. URL: http://www.ncchta.org/execsumm/summ837.htm. 3. BCBS/USA 2002: Rituximab for treatment of intermediate and aggressive B-cell non-Hodgkin's lymphomas. URL: http://www.bcbs.com/tec/vol17/17_03.html. 4. NCCHTA/GB 2002: Rituximab as thirdline treatment for refractory or recurrent Stage III or IV follicular non-Hodgkin's lymphoma:a systematic review and economic evaluation. URL: http://www.ncchta.org/execsumm/summ603.htm. |
| Language: | German |
| Number: | 32 |
| Deposited on: | 22 Aug 2007 14:19 |
| Last Modified: | 10 Jul 2025 11:10 |
Repository Staff Only: item control page